Binge Eating Disorder Archives

Dasotraline Development for ADHD, Binge Eating Disorder Halted, NDAs Withdrawn

By

May 14, 2020

n August 2018, the Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) stating the application required additional data to further assess the efficacy and tolerability of dasotraline.

Drugs in the Pipeline

Novel Binge Eating Disorder Treatment Accepted for Review by FDA

By

Steve Duffy

July 30, 2019

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for dasotraline (Sunovion) in the treatment of binge eating disorder.

Drugs in the Pipeline

Dasotraline Effective in Phase 3 Binge Eating Disorder Trial

By

Diana Ernst, RPh

July 25, 2018

The results from this trial follow similar positive findings from a flexible-dose study of dasotraline.